| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 107 |
| 1 | ETANERCEPT | 67 |
| 2 | PANTOPRAZOLE | 59 |
| 3 | GABAPENTIN | 55 |
| 4 | UPADACITINIB | 51 |
| 5 | LEVOTHYROXINE SODIUM | 50 |
| 6 | METHOTREXATE SODIUM | 45 |
| 7 | FUROSEMIDE | 43 |
| 8 | SODIUM OXYBATE | 43 |
| 9 | OMEPRAZOLE MAGNESIUM | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORZOXAZONE | 3 | 0.0023 |
| 1 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 15 | 0.0016 |
| 2 | ADALIMUMAB-AFZB | 4 | 0.0015 |
| 3 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 4 | 0.0015 |
| 4 | PITOLISANT HYDROCHLORIDE | 3 | 0.0014 |
| 5 | PATISIRAN | 3 | 0.0011 |
| 6 | SOLRIAMFETOL | 4 | 0.0010 |
| 7 | LURASIDONE HYDROCHLORIDE | 21 | 0.0010 |
| 8 | TERAZOSIN HYDROCHLORIDE | 8 | 0.0009 |
| 9 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 4 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 97 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 76 |
| 2 | GLP-1 Receptor Agonist [EPC] | 63 |
| 3 | Benzodiazepine [EPC] | 56 |
| 4 | Proton Pump Inhibitor [EPC] | 53 |
| 5 | Vitamin C [EPC] | 53 |
| 6 | Corticosteroid [EPC] | 52 |
| 7 | Janus Kinase Inhibitor [EPC] | 51 |
| 8 | Atypical Antipsychotic [EPC] | 48 |
| 9 | Loop Diuretic [EPC] | 48 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 4 | 0.0010 |
| 2 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 6 | 0.0006 |
| 5 | Sympathomimetic-like Agent [EPC] | 18 | 0.0006 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 9 | Aminosalicylate [EPC] | 38 | 0.0004 |